Loading...

Vivos Inc.

RDGLPNK
Healthcare
Medical - Devices
$0.07
$0.00(0.14%)
U.S. Market opens in 4h 57m

Vivos Inc. Fundamental Analysis

Vivos Inc. (RDGL) shows moderate financial fundamentals with a PE ratio of -10.27, profit margin of -44.84%, and ROE of -1.26%. The company generates $0.0B in annual revenue with strong year-over-year growth of 43.56%.

Key Strengths

PEG Ratio-0.10
Current Ratio14.00

Areas of Concern

ROE-1.26%
Operating Margin-46.29%
Cash Position4.92%
We analyze RDGL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3439.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3439.9/100

We analyze RDGL's fundamental strength across five key dimensions:

Efficiency Score

Weak

RDGL struggles to generate sufficient returns from assets.

ROA > 10%
-1.64%

Valuation Score

Excellent

RDGL trades at attractive valuation levels.

PE < 25
-10.27
PEG Ratio < 2
-0.10

Growth Score

Moderate

RDGL shows steady but slowing expansion.

Revenue Growth > 5%
43.56%
EPS Growth > 10%
8.97%

Financial Health Score

Excellent

RDGL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.07
Current Ratio > 1
14.00

Profitability Score

Weak

RDGL struggles to sustain strong margins.

ROE > 15%
-126.32%
Net Margin ≥ 15%
-44.84%
Positive Free Cash Flow
No

Key Financial Metrics

Is RDGL Expensive or Cheap?

P/E Ratio

RDGL trades at -10.27 times earnings. This suggests potential undervaluation.

-10.27

PEG Ratio

When adjusting for growth, RDGL's PEG of -0.10 indicates potential undervaluation.

-0.10

Price to Book

The market values Vivos Inc. at 18.96 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

18.96

EV/EBITDA

Enterprise value stands at -15.41 times EBITDA. This is generally considered low.

-15.41

How Well Does RDGL Make Money?

Net Profit Margin

For every $100 in sales, Vivos Inc. keeps $-44.84 as profit after all expenses.

-44.84%

Operating Margin

Core operations generate -46.29 in profit for every $100 in revenue, before interest and taxes.

-46.29%

ROE

Management delivers $-1.26 in profit for every $100 of shareholder equity.

-1.26%

ROA

Vivos Inc. generates $-1.64 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.64%

Following the Money - Real Cash Generation

Operating Cash Flow

Vivos Inc. generates limited operating cash flow of $-2.19M, signaling weaker underlying cash strength.

$-2.19M

Free Cash Flow

Vivos Inc. generates weak or negative free cash flow of $-2.30M, restricting financial flexibility.

$-2.30M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

RDGL converts -6.40% of its market value into free cash.

-6.40%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-10.27

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.10

vs 25 benchmark

P/B Ratio

Price to book value ratio

18.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

490.95

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.07

vs 25 benchmark

Current Ratio

Current assets to current liabilities

14.005

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.26

vs 25 benchmark

ROA

Return on assets percentage

-1.64

vs 25 benchmark

ROCE

Return on capital employed

-1.81

vs 25 benchmark

How RDGL Stacks Against Its Sector Peers

MetricRDGL ValueSector AveragePerformance
P/E Ratio-10.2729.43 Better (Cheaper)
ROE-126.32%692.00% Weak
Net Margin-4483.86%-44295.00% (disorted) Weak
Debt/Equity0.070.35 Strong (Low Leverage)
Current Ratio14.004.48 Strong Liquidity
ROA-164.17%-18045.00% (disorted) Weak

RDGL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Vivos Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

26.02%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

22.70%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

13.97%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ